Bioengineers have developed a new system inspired by the lotus leaf to advance cancer research.

By replicating the leaf's surface using a zinc oxide-based culturing platform, scientists are now able to model 3D nanoscale tumor progression with high precision.

This achievement could provide valuable insights into the characteristics of cancer cell clusters, potentially leading to improved treatment options.

Follow For More!

bioengineering #cancerresearch #lotusleaf #Innovation #HealthCare #technology #science #research #development #medicaladvancements #bioinspired

The Rapidly Growing Cell Separation Market is driven by Increasing R&D Investments in Cell-Based Research
The global cell separation market is estimated to be valued at US$ 9.90 billion in 2025 and is expected to exhibit a CAGR of 9.9% over the forecast period 2025-2032.

Cell Separation Market Demand has witnessed significant growth in the recent past owing to rising research in cell-based therapies, personalized medicine and molecular biology. Cell separation finds widespread usage in isolation of stem cells from bone marrow and umbilical cord, separation of white and red blood cells, and isolation of tumor cells from patient blood samples.

Cell Separation Market- https://articlescad.com/ce...

#CoherentMarketInsights #StemCellResearch #RegenerativeMedicine #ChronicDiseases #cancerresearch

New Study Unveils Shared Immune Suppression Mechanism in Cancer and Pregnancy

In a groundbreaking study recently published in Cell, a team of researchers has shed light on the shared immune tolerance mechanisms present in both cancer and pregnancy.

The study zeroes in on the role of progestogen-induced B7 Homolog 4 (B7-H4), an immune checkpoint protein, highlighting it as a crucial onco-fetal immune tolerance checkpoint. This mechanism facilitates the immune system’s acceptance of both cancerous and fetal cells.

Know More: https://thelifesciencesmag...

#cancerresearch #Pregnancy #immunesystem #immunotolerance #celljournal #oncology #fetaldevelopment #B7H4 #immunocheckpoint #groundbreakingstudy

UQ Research Paves the Way for Advanced Bladder Cancer Immunotherapy

The University of Queensland (UQ) has made significant strides in bladder cancer research, potentially revolutionizing treatment options with a novel immunotherapy approach.

Led by Associate Professor Fernando Guimaraes at UQ’s Frazer Institute, the research team has uncovered a critical mechanism by which bladder cancer evades the immune system’s natural killer (NK) cells.

Know More: https://thelifesciencesmag...

#UQResearch #BladderCancer #Immunotherapy #AdvancedBladderCancer #cancerresearch #MedicalResearch #UQ #UniversityofQueensland #Breakthrough #Innovation #HealthCare #medicine

Lomustine: A Key Player in Cancer Treatment

With rising cancer cases especially brain tumors & lymphomas #Lomustine remains a crucial treatment option. 🌍 Advancements in #oncology , early detection, and improved healthcare access are driving its demand. Plus, its role in combination therapies & targeted treatments makes it even more vital.

Read More: https://wemarketresearch.c...

#CancerTreatment #oncology #healthcareinnovation #cancerresearch #BrainTumor #Lymphoma #chemotherapy #Pharma #MedicalBreakthrough #CancerAwareness #HealthCare #biotech #CancerSupport #CancerFighter #LifeSavingTreatment

The Cancer Stem Cells Market is gaining attention for its potential in developing novel cancer treatments. Research in this area focuses on targeting cancer stem cells that drive tumor growth and recurrence. Advances in understanding and manipulating these cells are paving the way for more effective therapies and improved patient outcomes.
https://www.analytica.glob...
#cancerresearch #StemCells #MedicalInnovation #biotech #HealthcareRevolution

Fusion Biopsy: Driven by Rising Cancer Incidence Rates
The Global Fusion Biopsy Market is estimated to be valued at US$ 791.1 Mn in 2025 and is expected to exhibit a CAGR of 8.7% over the forecast period 2025-2032.

Fusion Biopsy Market Growth is incidence of cancer cases worldwide is driving the demand for fusion biopsy.
Major players are expanding their presence globally, especially in emerging markets of Asia Pacific and Latin America. Market players are focusing on partnerships and collaborations with hospitals and diagnostic centers to increase the adoption of fusion biopsy systems. Geographical expansion enables access to large patient pools in untapped markets.

Fusion Biopsy Market-https://articlescad.com/fu...

#CoherentMarketInsights #StemCellResearch #RegenerativeMedicine #cancerresearch #ChronicDiseases

The Clinical Oncology Next-Generation Sequencing Market size was valued at USD 9.49 Billion in 2023 and the total Clinical Oncology Next-Generation Sequencing revenue is expected to grow at a CAGR of 20.7 % from 2024 to 2030, reaching nearly USD 35.42 Billion by 2030.

#OncologySequencing
#NGSMarket
#cancerresearch
#NextGenSequencing
#ClinicalOncology